Literature DB >> 19189910

Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence.

Diana B Petitti1, Steven M Teutsch, Mary B Barton, George F Sawaya, Judith K Ockene, Thomas DeWitt.   

Abstract

The U.S. Preventive Services Task Force (USPSTF) seeks to provide reliable and accurate evidence-based recommendations to primary care clinicians. However, clinicians indicate frustration with the lack of guidance provided by the USPSTF when the evidence is insufficient to make a recommendation. This article describes a new USPSTF plan to commission its Evidence-based Practice Centers to collect information in 4 domains pertinent to clinical decisions about prevention and to report this information routinely. The 4 domains are potential preventable burden, potential harm of the intervention, costs (both monetary and opportunity), and current practice. The process and rationale used to select these domains are presented, along with examples of how clinicians might use the information to guide clinical decision making when evidence is insufficient.

Mesh:

Year:  2009        PMID: 19189910     DOI: 10.7326/0003-4819-150-3-200902030-00010

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  30 in total

1.  CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.

Authors:  M V Relling; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2011-01-26       Impact factor: 6.875

2.  Clinical preventive services for older adults: the interface between personal health care and public health services.

Authors:  Lydia L Ogden; Chesley L Richards; Douglas Shenson
Journal:  Am J Public Health       Date:  2012-01-19       Impact factor: 9.308

3.  Predictive genetic testing, risk communication, and risk perception: an international expert meeting in Berlin, Germany.

Authors:  Eva Fisher; Steffi Achilles; Holger Tönnies
Journal:  J Community Genet       Date:  2013-12-10

Review 4.  A Youth Suicide Prevention Plan for Canada: A Systematic Review of Reviews.

Authors:  Kathryn Bennett; Anne E Rhodes; Stephanie Duda; Amy H Cheung; Katharina Manassis; Paul Links; Christopher Mushquash; Peter Braunberger; Amanda S Newton; Stanley Kutcher; Jeffrey A Bridge; Robert G Santos; Ian G Manion; John D Mclennan; Alexa Bagnell; Ellen Lipman; Maureen Rice; Peter Szatmari
Journal:  Can J Psychiatry       Date:  2015-06       Impact factor: 4.356

5.  National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy.

Authors:  Mette Jensen Stochkendahl; Per Kjaer; Jan Hartvigsen; Alice Kongsted; Jens Aaboe; Margrethe Andersen; Mikkel Ø Andersen; Gilles Fournier; Betina Højgaard; Martin Bach Jensen; Lone Donbæk Jensen; Ture Karbo; Lilli Kirkeskov; Martin Melbye; Lone Morsel-Carlsen; Jan Nordsteen; Thorvaldur Skuli Palsson; Zoreh Rasti; Peter Frost Silbye; Morten Zebitz Steiness; Simon Tarp; Morten Vaagholt
Journal:  Eur Spine J       Date:  2017-04-20       Impact factor: 3.134

6.  Management of incidental findings in clinical genomic sequencing.

Authors:  Joel B Krier; Robert C Green
Journal:  Curr Protoc Hum Genet       Date:  2013

7.  Reducing Health Disparities Through Prevention: Role of the U.S. Preventive Services Task Force.

Authors:  Matthew J O'Brien; Kate A Kirley; Ronald T Ackermann
Journal:  Am J Prev Med       Date:  2020-02-24       Impact factor: 5.043

Review 8.  An overview of preoperative glucose evaluation, management, and perioperative impact.

Authors:  Ann M Sheehy; Robert A Gabbay
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

Review 9.  Structured decision-making drives guidelines panels' recommendations "for" but not "against" health interventions.

Authors:  Benjamin Djulbegovic; Tea Reljic; Shira Elqayam; Adam Cuker; Iztok Hozo; Qi Zhou; Shelly-Anne Li; Paul Alexander; Robby Nieuwlaat; Wojtek Wiercioch; Holger Schünemann; Gordon Guyatt
Journal:  J Clin Epidemiol       Date:  2019-02-16       Impact factor: 6.437

Review 10.  Prioritizing genomic applications for action by level of evidence: a horizon-scanning method.

Authors:  W D Dotson; M P Douglas; K Kolor; A C Stewart; M S Bowen; M Gwinn; A Wulf; H M Anders; C Q Chang; M Clyne; T K Lam; S D Schully; M Marrone; W G Feero; M J Khoury
Journal:  Clin Pharmacol Ther       Date:  2014-02-19       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.